← Evidence map

ArticleDiscover oncology2024

SLC1A3 is a novel prognostic biomarker associated with immunity and EMT in hepatocellular carcinoma.

Renhou Zhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39560677